Page 1 of Clinical Trials for gastroesophageal junction, 215 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction
Last Updated: August 19, 2011
Condition(s): Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer
2
Active, not recruiting
Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
Last Updated: January 29, 2011
Condition(s): Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer
3
Recruiting
ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction
Last Updated: October 20, 2011
Condition(s): Stomach Neoplasms; Gastroesophageal Junction Neoplasms
4
Recruiting
Combination Chemotherapy With or Without GDC-0449 in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Last Updated: April 2, 2011
Condition(s): Adenocarcinoma of the Gastroesophageal Junction; Gastric Cancer
5
Recruiting
MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Last Updated: May 24, 2012
Condition(s): Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer; Gastric Cancer
6
Recruiting
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Last Updated: May 19, 2012
Condition(s): Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer; Gastric Cancer
7
Recruiting
Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction
Last Updated: December 9, 2011
Condition(s): Adenocarcinoma of the Gastroesophageal Junction; Gastric Cancer
8
Recruiting
Combination Chemotherapy in Treating Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer
Last Updated: May 24, 2012
Condition(s): Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer; Gastric Cancer
9
Recruiting
Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer
Last Updated: November 19, 2011
Condition(s): Adenocarcinoma of the Gastroesophageal Junction; Gastric Cancer
10
Recruiting
Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction
Last Updated: January 31, 2012
Condition(s): Adenocarcinoma of the Gastroesophageal Junction
11
Active, not recruiting
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
Last Updated: February 1, 2012
Condition(s): Gastric Cancer; Esophageal Cancer
12
Active, not recruiting
Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG)
Last Updated: March 27, 2012
Condition(s): Adenocarcinomas of the Esophagogastric Junction
13
Recruiting
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Last Updated: May 23, 2012
Condition(s): Gastroesophageal Junction Adenocarcinoma; Gastric Cancer
14
Recruiting
Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach
Last Updated: January 2, 2012
Condition(s): Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach
15
Recruiting
Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Last Updated: October 20, 2008
Condition(s): Gastric Junction Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma
16
Active, not recruiting
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Last Updated: April 25, 2012
Condition(s): Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach; Squamous Cell Carcinoma of the Esophagus; Stage II Esophageal Cancer; Stage II Gastric Cancer; Stage III Esophageal Cancer; Stage III Gastric Cancer
17
Recruiting
Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Last Updated: June 22, 2011
Condition(s): Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma
18
Recruiting
Epirubicin, Oxaliplatin, and Capecitabine or Docetaxel and Oxaliplatin in Treating Patients With Advanced Esophageal Cancer, Gastroesophageal Junction Cancer, or Stomach Cancer
Last Updated: June 30, 2010
Condition(s): Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer; Gastric Cancer
19
Active, not recruiting
Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma
Last Updated: February 15, 2011
Condition(s): Stomach Cancer; Gastric Cancer; Gastro-esophageal Junction Cancer
20
Recruiting
Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer
Last Updated: April 18, 2012
Condition(s): Esophageal Cancer; Gastroesophageal Junction Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=gastroesophageal+junction

Page 1 of Clinical Trials for gastroesophageal junction, 215 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About